Skin cancer is caused by DNA damage in skin cells. The most common source of that damage is ultraviolet radiation from the ...

Oral cancer often arrives quietly but leaves a devastating mark. Among the many forms it can take, oral squamous cell carcinoma (OSCC) stands out as the most common and one of the most dangerous. Its ...

Researchers have developed a compact, noninvasive imaging system that combines high-resolution structural imaging with ...

Head and neck squamous cell carcinomas (HNSCC) are a group of cancers that affect cells in and around our mouth and nose.

People with locally advanced head and neck squamous cell carcinoma (HNSCC) now have a new treatment option that could extend their lives with fewer side effects. The U.S. Food and Drug Administration ...

Neo-adjuvant nivolumab or nivolumab with ipilimumab in advanced cutaneous squamous cell carcinoma prior to surgery. ClinicalTrials.gov. Updated October 26, 2022.

The receptor for the complement component C5a may be a useful therapeutic target for cases of cutaneous squamous cell carcinoma (cSCC), according to a new report. 1 The study, published in the ...

Traws Pharma published key clinical efficacy data for rigosertib in patients with RDEB-associated squamous cell carcinoma. What is rigosertib being evaluated for?

Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...

Patients who have cutaneous squamous-cell carcinoma with high-risk features are at risk for recurrence after definitive local therapy. The benefit of systemic adjuvant therapy options has not been ...

Alliance trial shows dual immunotherapy improves progression-free survival in advanced squamous cell skin cancer Avelumab plus cetuximab combination meets primary endpoint in phase II trial ...

Survival for head and neck squamous cell carcinoma treated with versus without neoadjuvant systemic therapy: A national propensity score–matched analysis.. If you have the appropriate software ...